Aurisco Pharmaceutical Co.,Ltd. (605116.SS) SHH

Currency In CNY

AD

Valuation

Market Cap10.05B
Enterprise Value10.29B
P/E Ratio20.71
PEG Ratio-6.83
Price/Sales Ratio4.79
Price/Book Ratio2.92
Enterprise/Revenue4.96
Enterprise/EBITDA14.62

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.23
Operating Margin0.28
AD

Management Effectiveness

Return On Assets0.09
Return On Equity0.15

Income Statement

Revenue1.7B
Revenue/Share4.22
Gross Profit1.01B
EBITDA678.98M
Net Income449.21M
Diluted EPS1.1

Balance Sheet

Total Cash917.17M
Total Cash/Share2.3
Total Debt969.5M
Total Debt/Equity0.36
Current Ratio4.22
Book Value Per Share6.8

Price History

52-Week Change-2.79
52-Week High35.58
52-Week Low18.09
Moving Average 50 Days22.07
Moving Average 200 Days24.28

Statistics

Average Volume5.8M
Shares Outstanding406.18M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.34
Trailing Annual Dividend Yield1.71
Payout Ratio0.31
Last Split FactorN/A
Last Split DateN/A
AD